Brimonidine Tartrate Ophthalmic Solution Solution/ Drops
Product Images NDC 70756-677

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate Ophthalmic Solution (NDC 70756-677). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lifestar Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (3b8042bb 0691 4159 8787 Cba97a9e3c5a 01)

Structure (3b8042bb 0691 4159 8787 Cba97a9e3c5a 01)
Chemical structure of Brimonidine Tartrate, the active ingredient in Brimonidine Tartrate Ophthalmic Solution 1 mg/mL by Lifestar Pharma LLC. The structure shows molecular connectivity including a brominated aromatic ring and tartrate component.*
FDA Label Image

5 mL Label (3b8042bb 0691 4159 8787 Cba97a9e3c5a 02)

5 mL Label (3b8042bb 0691 4159 8787 Cba97a9e3c5a 02)
Label of Brimonidine Tartrate Ophthalmic Solution 0.1% sterile solution for eye use only, 5 mL bottle. The label indicates prescription-only status, manufacturer Lifestar Pharma LLC located in Mahwah, NJ, with product origin Spain. Storage instructions specify 20°C to 25°C. Includes usual dosage instructions and a barcode.*
FDA Label Image

Carton 5 mL (3b8042bb 0691 4159 8787 Cba97a9e3c5a 03)

Carton 5 mL (3b8042bb 0691 4159 8787 Cba97a9e3c5a 03)
Packaging label for Brimonidine Tartrate Ophthalmic Solution 0.1%, an eye drop solution in a 5 mL bottle from Lifestar Pharma LLC. The label includes dosage concentration, sterile status, and usage indication for eye application only, with storage instructions and active ingredient details. It also features barcode and manufacturing information.*
FDA Label Image

10ml Label (3b8042bb 0691 4159 8787 Cba97a9e3c5a 04)

10ml Label (3b8042bb 0691 4159 8787 Cba97a9e3c5a 04)
Label for Brimonidine Tartrate Ophthalmic Solution 0.1%, 10 mL sterile eye drops. The label indicates it is prescription only for ophthalmic use, manufactured for Lifestar Pharma LLC. Includes storage instructions and dosage information, with a barcode and product origin as Spain.*
FDA Label Image

10 mL Carton (3b8042bb 0691 4159 8787 Cba97a9e3c5a 05)

10 mL Carton (3b8042bb 0691 4159 8787 Cba97a9e3c5a 05)
Label for Brimonidine Tartrate Ophthalmic Solution 0.1% by Lifestar Pharma LLC. The 10 mL sterile eye drops are for ophthalmic use only and labeled Rx only. The label includes active and inactive ingredients, dosage instructions, storage information, and warnings about child safety. Packaging indicates product is made in Spain and contains barcode and NDC 70756-678-30.*
FDA Label Image

15 mL Label (3b8042bb 0691 4159 8787 Cba97a9e3c5a 06)

15 mL Label (3b8042bb 0691 4159 8787 Cba97a9e3c5a 06)
Label for Brimonidine Tartrate Ophthalmic Solution 0.1%, sterile eye drops in a 15 mL container by Lifestar Pharma LLC. It includes dosage instructions, storage information, preservative details, and manufacturer address. The label shows the NDC 70756-679-35 and states the product is for prescription use only.*
FDA Label Image

15 mL Carton (3b8042bb 0691 4159 8787 Cba97a9e3c5a 07)

15 mL Carton (3b8042bb 0691 4159 8787 Cba97a9e3c5a 07)
Label for Brimonidine Tartrate Ophthalmic Solution 0.1%, a sterile eye drop solution in a 15 mL bottle. The label includes the active ingredient concentration, usage instructions for eye use only, and storage conditions. It is manufactured for Lifestar Pharma LLC in Mahwah, NJ, USA, with a product NDC of 70756-679-35.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.